Brinker Capital Investments’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$803K	Sell	13,817 -590	-4%	-$27.2K	0.01%	1235
2025 Q4	$646K	Sell	14,407 -511	-3%	-$21.5K	﹤0.01%	1478
2025 Q3	$599K	Buy	14,918 +2	+0%	+$70	﹤0.01%	1475
2025 Q2	$467K	Sell	14,916 -615	-4%	-$20.1K	﹤0.01%	1532
2025 Q1	$521K	Buy	15,531 +2,095	+16%	+$79.5K	0.01%	1406
2024 Q4	$527K	Sell	13,436 -1,067	-7%	-$44.1K	0.01%	1333
2024 Q3	$571K	Sell	14,503 -11	-0.1%	-$444	0.01%	1288
2024 Q2	$566K	Buy	14,514 +816	+6%	+$32.6K	0.01%	1235
2024 Q1	$590K	Buy	13,698 +5,481	+67%	+$252K	0.01%	1198
2023 Q4	$393K	Sell	8,217 -7,185	-47%	-$254K	﹤0.01%	1301
2023 Q3	$526K	Sell	15,402 -404	-3%	-$15.1K	0.01%	1187
2023 Q2	$609K	Buy	+15,806	New	+$628K	0.01%	1148